{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:58:53Z","timestamp":1762459133140},"reference-count":12,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Clinical Trials"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1310\/hct1403-81","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T01:06:44Z","timestamp":1373332004000},"page":"81-91","source":"Crossref","is-referenced-by-count":57,"title":["Rilpivirine Versus Efavirenz in HIV-1\u2013Infected Subjects Receiving Emtricitabine\/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies"],"prefix":"10.1080","volume":"14","author":[{"given":"M.R.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Elion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"Hodder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Segal-Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Garner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Guyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Chuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vanveggel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Deckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,12,22]]},"reference":[{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7961"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60936-7"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60983-5"},{"key":"CIT0011","volume-title":"Clinical Considerations for Accelerated and Traditional Approval of Antiretroviral Drugs Using Plasma HIV RNA Measurements - Guidance for Industry","year":"2002"},{"issue":"5","key":"CIT0015","first-page":"138","volume":"17","author":"Johnson VA","year":"2009","journal-title":"Top HIV Med"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/135965350901400114","volume":"14","author":"Tambuyzer L","year":"2009","journal-title":"Antivir Ther"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31823aca74"},{"issue":"21","key":"CIT0021","first-page":"11309","volume":"201185","author":"Hu Z","journal-title":"J Virol"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05584-11"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834168b"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834c4c06"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328353b047"}],"container-title":["HIV Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1310\/hct1403-81","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T03:33:50Z","timestamp":1715657630000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1310\/hct1403-81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,12,22]]},"published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1310\/hct1403-81"],"URL":"https:\/\/doi.org\/10.1310\/hct1403-81","relation":{},"ISSN":["1528-4336","1945-5771"],"issn-type":[{"value":"1528-4336","type":"print"},{"value":"1945-5771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}